President Donald Trump's administration is pushing for a ceasefire agreement with Iran on Monday as Vice President JD Vance ...

The industry was a darling of the venture capital world 10 years ago. With many farms out of business, the remaining companies have scaled back.

On March 21, a Palestinian vehicle collided with an ATV near the village of Beit Imrin in the West Bank, killing the ATV driver. Had it not been for the fact that the driver of the ATV was 18-year-old ...

Thompson crafted a dark terrain prowled by con artists, corrupt lawmen and assorted fugitives.

A long-duration heat wave is taking shape over the western half of the U.S. and is forecast to stick around in the days ahead. A high-pressure system in place over the West is keeping precipitation ...

Eric Mandel, writing in the Jerusalem Post on March 16, calls Iran’s war “a war of attrition”. The loss of its current leadership through targeted assassination is unlikely to affect this survival ...

Catch a ride with one of the rising clubs of American soccer with our San Diego Wave TV schedule. One of NWSL’s newest clubs has not yet made a splash on the field, but they’ve emerged as a model for ...

Wave Life Sciences linked its obesity drug candidate to a 1% dip in body weight after six months, leading investors to drive the stock down by more than 50% despite the biotech hailing the data as ...

D-Wave Quantum isn't pursuing a general-purpose quantum computer. The stock is a risky investment. While most of the investor focus in the tech world may be on artificial intelligence (AI), there's ...

Former US Ambassador to China Nicholas Burns breaks down the global stakes of the Iran conflict, the war in Ukraine, and tensions with China. Burns discusses the way Iran could reshape geopolitical ...

Meteorologists are reaching for superlatives to describe an oncoming heat wave so intense and rare for this time of year that it could leave some locations shattering their all-time temperature ...

Wave Life Sciences (WVE) fell ~57% in the premarket on Thursday as Wall Street reacted to interim data from an early-stage trial for WVE-007, its RNA-based obesity medicine. Citing six-month follow-up ...